ImmunoKey at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

ImmunoKey takes part in 2 sessions at Cell 2026 in London. Its sessions centre on next-generation CAR-T cell therapy for solid cancers and the route from discovery to delivery. The specific topic is its CARKey technology for tackling tumours whose target antigens vary from cell to cell.

OrganizationCell 2026 Attendance
ImmunoKey
Macclesfield, UK
Biotech
Develops CARKey, a CAR-T platform designed to overcome antigen heterogeneity in solid cancers.
Talk
Fri Nov 13
1:55pm–2:20pm
Overcoming Antigen Heterogeneity In Solid Cancer Using CARKey Technology
Cell and gene therapy
Panel
Fri Nov 13
2:45pm–3:10pm
From Discovery To Deliverability: Building The Next Generation Of Cell Therapies
with Novo Nordisk Foundation Cellerator
Cell and gene therapy

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ImmunoKey

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction